Richest people in healthcare
252 billionaires worth a combined $963B, ranked by Forbes real-time estimates on October 11, 2026. Thomas Frist Jr & family leads at $36.9B.
Ranking
| Name | Rank | Net worth | Since 2026 list | Age | Source | Country |
|---|
| Thomas Frist Jr & family | 61 | $36.9B | -$4.2B | 88 | Hospitals | United States |
| Cyrus Poonawalla | 91 | $26.4B | -$583M | 85 | Vaccines | India |
| Dilip Shanghvi | 103 | $24.5B | -$1.1B | 71 | Pharmaceuticals | India |
| Zhong Huijuan | 160 | $17.1B | -$1.6B | 65 | Pharmaceuticals | China |
| Murali Divi & family | 229 | $13.6B | +$3.5B | 75 | Pharmaceuticals | India |
| Robert Duggan | 237 | $13.5B | +$1.9B | 82 | Pharmaceuticals | United States |
| Patrick Soon-Shiong | 282 | $11.8B | +$1.3B | 74 | Pharmaceuticals | United States |
| Ernesto Bertarelli | 302 | $11.5B | -$120M | 61 | Biotech, investments | Switzerland |
| Andreas Struengmann & family | 314 | $11.3B | -$710M | 76 | Pharmaceuticals | Germany |
| Thomas Struengmann & family | 314 | $11.3B | -$710M | 76 | Pharmaceuticals | Germany |
| Charlie Mills | 327 | $11.0B | -$417M | 65 | Medical supplies | United States |
| Sun Piaoyang | 335 | $10.8B | -$1.6B | 68 | Pharmaceuticals | China |
| Li Xiting | 343 | $10.6B | -$566M | 75 | Medical devices | Singapore |
| Li Ge | 354 | $10.3B | +$2.7B | 59 | Pharmaceuticals | United States |
| Zhu Yi | 355 | $10.3B | -$1.3B | 62 | Pharmaceuticals | China |
| Sulaiman Al Habib | 363 | $10.1B | -$139M | 74 | Hospital group | Saudi Arabia |
| Pankaj Patel | 394 | $9.2B | +$1.0B | 73 | Pharmaceuticals | India |
| Jorge Moll Filho & family | 422 | $8.9B | +$1.4B | 81 | Hospitals | Brazil |
| Carl Cook | 427 | $8.8B | -$2.9B | 64 | Medical devices | United States |
| Hasmukh Chudgar & family | 449 | $8.4B | +$846M | 93 | Pharmaceuticals | India |
| Seo Jung-jin | 456 | $8.3B | -$1.6B | 68 | Biotech | South Korea |
| Viktor Kharitonin | 495 | $7.9B | -$50M | 53 | Pharmaceuticals | Russia |
| Sudhir Mehta | 524 | $7.5B | -$558M | 72 | Pharmaceuticals, power | India |
| Samir Mehta | 525 | $7.5B | -$558M | 63 | Pharmaceuticals, power | India |
| Wolfgang Marguerre & family | 529 | $7.5B | -$398M | 85 | Pharmaceuticals | Germany |
| Massimiliana Landini Aleotti & family | 533 | $7.5B | -$1.7B | 83 | Pharmaceuticals | Italy |
| Dona Bertarelli | 540 | $7.4B | -$86M | 58 | Biotech and investments | Switzerland |
| Stéphane Bancel | 550 | $7.2B | +$5.2B | 54 | Biotech, vaccines | France |
| Xu Hang | 559 | $7.1B | -$153M | 64 | Medical devices | Hong Kong |
| Frederik Paulsen | 595 | $6.9B | -$846M | 75 | Health care | Sweden |
| Ronda Stryker | 604 | $6.7B | -$1.8B | 72 | Medical equipment | United States |
| Rudolf Maag | 606 | $6.7B | -$118M | 80 | Medical devices | Switzerland |
| John Brown | 625 | $6.4B | -$2.1B | 92 | Medical equipment | United States |
| Albert Boehringer | 639 | $6.3B | -$311M | 85 | Pharmaceuticals | Germany |
| Barbara Boehringer | 639 | $6.3B | -$311M | 54 | Pharmaceuticals | Germany |
| Christian Boehringer | 639 | $6.3B | -$311M | 61 | Pharmaceuticals | Germany |
| Christoph Boehringer | 639 | $6.3B | -$311M | 56 | Pharmaceuticals | Germany |
| Erich von Baumbach | 639 | $6.3B | -$311M | 55 | Pharma | Germany |
| Franz von Baumbach | 639 | $6.3B | -$311M | 25 | Pharma | Germany |
| Hubertus von Baumbach | 639 | $6.3B | -$311M | 58 | Pharma | Germany |
| Isabel Boehringer | 639 | $6.3B | -$311M | 46 | Pharmaceuticals | Germany |
| Johannes von Baumbach | 639 | $6.3B | -$311M | 21 | Pharma | Germany |
| Katharina von Baumbach | 639 | $6.3B | -$311M | 27 | Pharma | Germany |
| Mathias Boehringer | 639 | $6.3B | -$311M | 57 | Pharmaceuticals | Germany |
| Maximilian von Baumbach | 639 | $6.3B | -$311M | 28 | Pharma | Germany |
| Otto Boehringer | 639 | $6.3B | -$311M | 96 | Pharmaceuticals | Germany |
| Philipp Boehringer | 639 | $6.3B | -$311M | 48 | Pharmaceuticals | Germany |
| Ulrike von Baumbach | 639 | $6.3B | -$311M | 84 | Pharma | Germany |
| Alain Merieux & family | 665 | $6.2B | -$1.1B | 88 | Pharmaceuticals | France |
| Reinhold Schmieding | 718 | $5.8B | -$222M | 71 | Medical devices | United States |
| Cen Junda | 728 | $5.7B | -$1.6B | 62 | Pharmaceuticals | China |
| Chen Bang | 749 | $5.6B | -$1.2B | 61 | Hospitals | China |
| Andy Mills | 765 | $5.4B | -$261M | 65 | Medical supplies | United States |
| Lutz Mario Helmig & family | 793 | $5.3B | -$1.4B | 80 | Hospitals | Germany |
| Jerzy Starak | 824 | $5.2B | -$326M | 78 | Pharmaceuticals | Poland |
| Zhu Baoguo & family | 847 | $5.1B | -$541M | 64 | Pharmaceuticals | China |
| Jiang Rensheng & family | 858 | $5.0B | -$457M | 73 | Vaccines | China |
| Willy Michel | 863 | $5.0B | +$814M | 79 | Medical devices | Switzerland |
| Hu Baifan | 869 | $5.0B | -$626M | 64 | Pharmaceuticals | China |
| Jon Stryker | 870 | $5.0B | -$730M | 68 | Medical equipment | United States |
| B. Partha Saradhi Reddy | 881 | $4.9B | +$1.5B | 72 | Pharmaceuticals | India |
| Sergio Stevanato & family | 898 | $4.8B | +$904M | 83 | Medical packaging | Italy |
| Hansjoerg Wyss | 911 | $4.8B | +$62M | 91 | Medical devices | Switzerland |
| Thomas Straumann | 915 | $4.7B | -$551M | 63 | Dental implants | Switzerland |
| Stewart Rahr | 920 | $4.7B | +$405M | 80 | Drug distribution | United States |
| Egor Kulkov | 922 | $4.7B | -$1M | 54 | Pharmaceuticals | Russia |
| Keith Dunleavy & family | 932 | $4.6B | +$1.2B | 57 | Health IT, Investments | United States |
| Wendy Abrams | 933 | $4.6B | -$54M | 61 | Medical supplies | United States |
| August Troendle | 959 | $4.5B | +$1.0B | 70 | Pharmaceutical services | United States |
| Cheng Cheung Ling | 986 | $4.4B | n/a | 62 | pharmaceuticals | China |
| Maurizio Billi | 1008 | $4.3B | +$78M | 68 | Generic drugs | Brazil |
| Nancy Mills Barnett | 1010 | $4.3B | -$135M | 63 | Medical supplies | United States |
| Roger Samuelsson | 1028 | $4.1B | +$41M | 62 | Drug delivery devices | Sweden |
| Ugur Sahin | 1030 | $4.1B | -$567M | 61 | Biotechnology | Germany |
| Niels Peter Louis-Hansen | 1056 | $4.0B | -$676M | 78 | Medical devices | Denmark |
| P.V. Ramprasad Reddy | 1068 | $4.0B | +$972M | 68 | Pharmaceuticals | India |
| Ranjan Pai | 1070 | $4.0B | +$1.2B | 53 | Education, healthcare | India |
| Gilles Martin | 1071 | $4.0B | +$262M | 62 | Laboratory services | France |
| Ajay Piramal | 1074 | $4.0B | +$950M | 71 | Pharmaceuticals | India |
| Pat Stryker | 1076 | $3.9B | -$160M | 70 | Medical equipment | United States |
| Bernard Fraisse & family | 1080 | $3.9B | -$965M | 70 | Pharmaceuticals | France |
| Margaret Baker | 1102 | $3.8B | -$57M | 61 | Medical supplies | United States |
| David Dean Halbert | 1103 | $3.8B | +$1.2B | 70 | Biotech | United States |
| Otto Philipp Braun | 1106 | $3.8B | -$171M | 48 | Medical technology | Germany |
| Anne Beaufour | 1144 | $3.7B | -$796M | 63 | Pharmaceuticals | France |
| Dennis Bastas | 1149 | $3.7B | -$117M | 60 | pharmaceuticals | Australia |
| Prathap Reddy | 1174 | $3.6B | +$4M | 94 | Healthcare | India |
| Cai Dongchen | 1194 | $3.6B | -$346M | 73 | Pharmaceuticals | China |
| Leena Tewari | 1219 | $3.5B | +$251M | 69 | Pharmaceuticals | India |
| Jack Gance | 1265 | $3.4B | -$247M | 80 | Pharmacies | Australia |
| Wayne Rothbaum | 1313 | $3.2B | +$342M | 58 | Biotech investing | United States |
| Xue Min | 1315 | $3.2B | -$563M | 69 | Healthcare | China |
| Tse Ping & family | 1340 | $3.2B | -$4.6B | 74 | Pharmaceuticals | China |
| Xie Liangzhi & family | 1358 | $3.1B | +$612M | 60 | Biotech | China |
| Alberto Siccardi & family | 1360 | $3.1B | -$1.1B | 82 | Medical devices | Switzerland |
| Sam Gance | 1367 | $3.1B | -$204M | 77 | pharmacies | Australia |
| Timothy Springer | 1381 | $3.1B | +$2.0B | 78 | Biotech | United States |
| Mahima Datla | 1402 | $3.0B | -$213M | 49 | Vaccines | India |
| Cao Longxiang & family | 1416 | $3.0B | -$33M | 69 | Pharmaceuticals | China |
| Kiran Mazumdar-Shaw | 1428 | $2.9B | -$575M | 73 | Biopharmaceuticals | India |
Wealth by country
- United States: 52 billionaires, $221B combined, richest Thomas Frist Jr & family
- India: 44 billionaires, $181B combined, richest Cyrus Poonawalla
- Germany: 35 billionaires, $167B combined, richest Andreas Struengmann & family
- China: 53 billionaires, $151B combined, richest Zhong Huijuan
- Switzerland: 15 billionaires, $60.1B combined, richest Ernesto Bertarelli
- France: 6 billionaires, $26.8B combined, richest Stéphane Bancel
- Russia: 8 billionaires, $23.1B combined, richest Viktor Kharitonin
- Brazil: 3 billionaires, $14.9B combined, richest Jorge Moll Filho & family
- Italy: 3 billionaires, $14.8B combined, richest Massimiliana Landini Aleotti & family
- South Korea: 4 billionaires, $13.3B combined, richest Seo Jung-jin
- Sweden: 3 billionaires, $13.1B combined, richest Frederik Paulsen
- Singapore: 2 billionaires, $12.5B combined, richest Li Xiting
- Hong Kong: 3 billionaires, $12.1B combined, richest Xu Hang
- Saudi Arabia: 2 billionaires, $12.0B combined, richest Sulaiman Al Habib
- Australia: 3 billionaires, $10.1B combined, richest Dennis Bastas
Questions people ask
Who is the richest person in healthcare?
Thomas Frist Jr & family is the richest person in healthcare, worth $36.9B on October 11, 2026, according to Forbes real-time estimates. Cyrus Poonawalla is next at $26.4B.
How many billionaires are there in healthcare?
Forbes tracks 252 billionaires in healthcare as of October 11, 2026, worth a combined $963B. The median net worth among them is $2.5B.
Are billionaires in healthcare getting richer this year?
The 239 of them who were also on the 2026 Forbes billionaires list are down 3.7% (-$36.5B) together since that list, comparing each person's real-time worth with their figure on it.
More lists